FI941377A0 - Neuroleptisiä 2-substituoituja perhydro-1-H-pyrido/1,2-a/-pyratsiineja - Google Patents

Neuroleptisiä 2-substituoituja perhydro-1-H-pyrido/1,2-a/-pyratsiineja

Info

Publication number
FI941377A0
FI941377A0 FI941377A FI941377A FI941377A0 FI 941377 A0 FI941377 A0 FI 941377A0 FI 941377 A FI941377 A FI 941377A FI 941377 A FI941377 A FI 941377A FI 941377 A0 FI941377 A0 FI 941377A0
Authority
FI
Finland
Prior art keywords
pct
pyrazines
neuroleptic
pyrido
substituted perhydro
Prior art date
Application number
FI941377A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI941377A7 (fi
FI941377L (fi
Inventor
Gene Michael Bright
Kishor Amratlal Desai
Thomas Francis Seeger
Teresa Annette Smolarek
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI941377A7 publication Critical patent/FI941377A7/fi
Publication of FI941377L publication Critical patent/FI941377L/fi
Publication of FI941377A0 publication Critical patent/FI941377A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI941377A 1991-09-25 1992-08-14 Neuroleptisiä 2-substituoituja perhydro-1-H-pyrido/1,2-a/-pyratsiineja FI941377A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76533291A 1991-09-25 1991-09-25
PCT/US1992/006625 WO1993006101A1 (en) 1991-09-25 1992-08-14 NEUROLEPTIC 2-SUBSTITUTED PERHYDRO-1-H-PYRIDO[1,2a]PYRAZINES

Publications (3)

Publication Number Publication Date
FI941377A7 FI941377A7 (fi) 1994-03-24
FI941377L FI941377L (fi) 1994-03-24
FI941377A0 true FI941377A0 (fi) 1994-03-24

Family

ID=25073279

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941377A FI941377A0 (fi) 1991-09-25 1992-08-14 Neuroleptisiä 2-substituoituja perhydro-1-H-pyrido/1,2-a/-pyratsiineja

Country Status (25)

Country Link
US (1) US5565453A (OSRAM)
EP (1) EP0607163B1 (OSRAM)
JP (1) JPH08827B2 (OSRAM)
CN (1) CN1071167A (OSRAM)
AT (1) ATE146178T1 (OSRAM)
AU (1) AU655071B2 (OSRAM)
BR (1) BR9206541A (OSRAM)
CA (1) CA2118936A1 (OSRAM)
CZ (1) CZ281775B6 (OSRAM)
DE (1) DE69215886T2 (OSRAM)
DK (1) DK0607163T3 (OSRAM)
ES (1) ES2096099T3 (OSRAM)
FI (1) FI941377A0 (OSRAM)
GR (1) GR3022483T3 (OSRAM)
HU (1) HUT71488A (OSRAM)
IL (1) IL103204A (OSRAM)
MX (1) MX9205385A (OSRAM)
MY (1) MY108303A (OSRAM)
NO (1) NO941084L (OSRAM)
NZ (1) NZ244473A (OSRAM)
PL (1) PL170889B1 (OSRAM)
PT (1) PT100891A (OSRAM)
TW (1) TW215090B (OSRAM)
WO (1) WO1993006101A1 (OSRAM)
ZA (1) ZA927306B (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731307A (en) * 1994-09-30 1998-03-24 Pfizer, Inc. Neuroleptic 2,7-disubtituted perhydro-1h-pyrido 1, 2-A!pyrazines
NZ290936A (en) * 1994-09-30 1998-01-26 Pfizer 2,7-substituted octahydro-1h-pyrido[1,2-a]pyrazine derivatives
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
EP1608648B1 (en) * 2003-03-12 2012-07-18 Pfizer Products Inc. Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
WO2014096212A1 (en) * 2012-12-20 2014-06-26 Janssen Pharmaceutica Nv NOVEL TRICYCLIC 3,4-DIHYDRO-2H-PYRIDO[1,2-α]PYRAZINE-1,6-DIONE DERIVATIVES AS GAMMA SECRETASE MODULATORS
KR102171710B1 (ko) 2013-01-17 2020-10-30 얀센 파마슈티카 엔.브이. 감마 세크레타제 조절 인자로서의 신규 치환 피리도-피페라지논 유도체
US10562897B2 (en) 2014-01-16 2020-02-18 Janssen Pharmaceutica Nv Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US4957916A (en) * 1988-08-05 1990-09-18 Janssen Pharmaceutica N.V. Antipsychotic 3-piperazinylbenzazole derivatives
NZ230045A (en) * 1988-08-05 1990-11-27 Janssen Pharmaceutica Nv 3-piperazinylbenzazole derivatives and pharmaceutical compositions
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
US4956368A (en) * 1989-07-24 1990-09-11 Bristol-Myers Company Metabolites and prodrug formulations of 8-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione

Also Published As

Publication number Publication date
NZ244473A (en) 1995-04-27
MX9205385A (es) 1993-03-01
DK0607163T3 (da) 1997-03-17
US5565453A (en) 1996-10-15
IL103204A (en) 1996-05-14
TW215090B (OSRAM) 1993-10-21
CN1071167A (zh) 1993-04-21
CA2118936A1 (en) 1993-04-01
FI941377A7 (fi) 1994-03-24
DE69215886D1 (de) 1997-01-23
FI941377L (fi) 1994-03-24
WO1993006101A1 (en) 1993-04-01
PL170889B1 (pl) 1997-02-28
MY108303A (en) 1996-09-30
ES2096099T3 (es) 1997-03-01
NO941084D0 (no) 1994-03-24
HUT71488A (en) 1995-11-28
BR9206541A (pt) 1995-04-25
GR3022483T3 (en) 1997-05-31
PT100891A (pt) 1993-10-29
AU655071B2 (en) 1994-12-01
DE69215886T2 (de) 1997-04-03
HU9400851D0 (en) 1994-06-28
IL103204A0 (en) 1993-02-21
JPH08827B2 (ja) 1996-01-10
CZ395792A3 (en) 1994-05-18
EP0607163B1 (en) 1996-12-11
ZA927306B (en) 1994-03-24
JPH06506701A (ja) 1994-07-28
NO941084L (no) 1994-03-24
AU2460992A (en) 1993-04-27
ATE146178T1 (de) 1996-12-15
EP0607163A1 (en) 1994-07-27
CZ281775B6 (cs) 1997-01-15

Similar Documents

Publication Publication Date Title
GB2270075B (en) Substituted 2-phenyl-3-methoxypropenoate fungicides
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
ZA918044B (en) Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines of piperazines,and compositions and methods of use thereof
FI951901L (fi) Stabiili pidennysti vapautuva, oraalisesti annosteltava koostumus
ES2164639T3 (es) Quinoxalinas, procedimiento para su preparacion y su empleo.
DE69201748D1 (de) Pyrazinderivate.
DK0607163T3 (da) Neuroleptiske 2-substituerede perhydro-1-H-pyrido- 1,2-a pyraziner
FI20000354L (fi) Perhydro-1H-pyrido/1,2-a/pyratsiinijohdannaiset
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
DK0777653T3 (da) Dihydropyridinderivater som bradykininantagonister
KR960004860B1 (en) Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments
ES2080320T3 (es) Medicamento inmunoestimulante a base de glicopeptidolipidos polares de mycobacterium chelonae.
ATE138662T1 (de) Antibiotische 7-aminonaphthazarinderivate
PT100001A (pt) Novos derivados glicosilicos inibidores da gluco-hidrolase uteis como agentes antidiabeticos
EP0509098A4 (en) Ataractic
FI990433A0 (fi) Neuroleptisiä perhydro-1H-pyrido(1,2-a)pyratsiineja
ES1024721Y (es) Zocalo para muebles perfeccionado.
GB9022046D0 (en) New 2-substituted n,n'-ditrimethoxybenzoyl piperazines
ES1018974Y (es) "cenicero perfeccionado".

Legal Events

Date Code Title Description
FD Application lapsed